A Study of Belimumab in Chinese Pediatric Participants With Systemic Lupus Erythematosus

Clinical trial NCT05917288 · COMPLETED

Trial details

NCT number: NCT05917288
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Systemic Lupus Erythematosus

Start date: 2023-07-07
Primary completion: 2024-10-30
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.